Rekah Pharmaceutical Industry Ltd. (REKA.TA)
ILA 1400.0
(0.43%)
ILA 1400.0
(0.43%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 148.84 Million ILS | 15.19% |
| 2022 | 129.21 Million ILS | -8.89% |
| 2021 | 141.82 Million ILS | 5.48% |
| 2020 | 134.46 Million ILS | 12.95% |
| 2019 | 119.04 Million ILS | 91.38% |
| 2018 | 62.2 Million ILS | -5.7% |
| 2017 | 65.96 Million ILS | -17.56% |
| 2016 | 80.01 Million ILS | 7.06% |
| 2015 | 74.73 Million ILS | -21.97% |
| 2014 | 95.78 Million ILS | 458.29% |
| 2013 | 17.15 Million ILS | -32.87% |
| 2012 | 25.55 Million ILS | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 140.08 Million ILS | -31.21% |
| 2024 Q2 | 101.78 Million ILS | -36.22% |
| 2023 Q2 | 135.31 Million ILS | 0.79% |
| 2023 FY | 148.84 Million ILS | 15.19% |
| 2023 Q1 | 134.24 Million ILS | 3.89% |
| 2023 Q4 | 148.84 Million ILS | 7.51% |
| 2023 Q3 | 138.45 Million ILS | 2.32% |
| 2022 FY | 129.21 Million ILS | -8.89% |
| 2022 Q2 | 141.58 Million ILS | 6.85% |
| 2022 Q3 | 133.21 Million ILS | -5.92% |
| 2022 Q4 | 129.21 Million ILS | -3.0% |
| 2022 Q1 | 132.51 Million ILS | -6.56% |
| 2021 FY | 141.82 Million ILS | 5.48% |
| 2021 Q4 | 141.82 Million ILS | -2.53% |
| 2021 Q3 | 145.5 Million ILS | 1.74% |
| 2021 Q1 | 126.39 Million ILS | -6.0% |
| 2021 Q2 | 143.01 Million ILS | 13.15% |
| 2020 Q3 | 136.04 Million ILS | 11.09% |
| 2020 Q1 | 135.96 Million ILS | 14.21% |
| 2020 Q2 | 122.46 Million ILS | -9.93% |
| 2020 Q4 | 134.46 Million ILS | -1.16% |
| 2020 FY | 134.46 Million ILS | 12.95% |
| 2019 Q3 | 94.27 Million ILS | 18.1% |
| 2019 FY | 119.04 Million ILS | 91.38% |
| 2019 Q2 | 79.82 Million ILS | -15.47% |
| 2019 Q1 | 94.44 Million ILS | 51.82% |
| 2019 Q4 | 119.04 Million ILS | 26.28% |
| 2018 Q1 | 83.69 Million ILS | 26.87% |
| 2018 Q4 | 62.2 Million ILS | -1.23% |
| 2018 Q3 | 62.98 Million ILS | -2.52% |
| 2018 Q2 | 64.6 Million ILS | -22.8% |
| 2018 FY | 62.2 Million ILS | -5.7% |
| 2017 Q3 | 67.15 Million ILS | -0.13% |
| 2017 FY | 65.96 Million ILS | -17.56% |
| 2017 Q2 | 67.24 Million ILS | -15.65% |
| 2017 Q1 | 79.72 Million ILS | -0.37% |
| 2017 Q4 | 65.96 Million ILS | -1.76% |
| 2016 Q1 | 92.57 Million ILS | 23.86% |
| 2016 FY | 80.01 Million ILS | 7.06% |
| 2016 Q4 | 80.01 Million ILS | -4.85% |
| 2016 Q3 | 84.09 Million ILS | 6.23% |
| 2016 Q2 | 79.16 Million ILS | -14.49% |
| 2015 FY | 74.73 Million ILS | -21.97% |
| 2015 Q4 | 74.73 Million ILS | -2.14% |
| 2015 Q3 | 76.37 Million ILS | -0.24% |
| 2015 Q2 | 76.55 Million ILS | -18.71% |
| 2015 Q1 | 94.17 Million ILS | -1.67% |
| 2014 Q1 | 83.05 Million ILS | 384.09% |
| 2014 FY | 95.78 Million ILS | 458.29% |
| 2014 Q4 | 95.78 Million ILS | -4.39% |
| 2014 Q3 | 100.18 Million ILS | -3.45% |
| 2014 Q2 | 103.75 Million ILS | 24.93% |
| 2013 Q1 | 23.37 Million ILS | -8.55% |
| 2013 Q3 | 19.05 Million ILS | -10.27% |
| 2013 FY | 17.15 Million ILS | -32.87% |
| 2013 Q2 | 21.23 Million ILS | -9.14% |
| 2013 Q4 | 17.15 Million ILS | -9.97% |
| 2012 FY | 25.55 Million ILS | 0.0% |
| 2012 Q4 | 25.55 Million ILS | -7.8% |
| 2012 Q3 | 27.71 Million ILS | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Cannabotech LTD | - ILA | -Infinity% |